Synjardy
Key Takeaways
- Synjardy combines empagliflozin and metformin in one tablet.
- It is used for adults with type 2 diabetes, not type 1 diabetes or diabetic ketoacidosis.
- Common side effects can include stomach upset, urinary symptoms, and dehydration-related effects.
- Kidney function, hydration, and other medicines matter when Synjardy is prescribed.
- Regular follow-up helps ensure the treatment remains safe and effective.
Synjardy is a prescription medicine used to help manage type 2 diabetes when lifestyle measures and a single medicine are not enough. It combines two established diabetes treatments that work in different ways to improve blood sugar control.
Overview
Synjardy is a prescription medicine used to help adults with type 2 diabetes manage blood glucose levels. It combines two different active ingredients, empagliflozin and metformin, so treatment can address blood sugar from more than one angle. For many people, this kind of combination is considered when one medicine alone is not giving enough control.
Empagliflozin belongs to a group called SGLT2 inhibitors. It helps the body remove extra glucose through the urine. Metformin reduces the amount of glucose the liver releases and helps the body use insulin more effectively. Used together, they can support steadier blood sugar control alongside diet, physical activity, and routine diabetes monitoring.
Synjardy is not a substitute for healthy daily habits, and it is not used to treat type 1 diabetes or diabetic ketoacidosis. A clinician decides whether it is appropriate by looking at blood sugar patterns, kidney function, other medicines, and overall health. For international patients, that decision often becomes part of a broader diabetes review, especially when care is being coordinated across countries and time zones.
Symptoms
Synjardy is not taken to treat symptoms in the immediate sense; it is prescribed to help improve the underlying blood sugar pattern. When type 2 diabetes is better controlled, people may notice fewer symptoms related to high glucose, such as excessive thirst, frequent urination, tiredness, or blurry vision. These changes usually happen gradually rather than overnight.
Because Synjardy can cause side effects, it is also helpful to know what new symptoms deserve attention after treatment begins. Some effects are mild and settle with time, while others suggest that the body may not be tolerating the medicine well. Common concerns can include stomach upset, gas, nausea, increased urination, dizziness, or signs of dehydration.
Less common but important symptoms may include genital irritation or infection, urinary discomfort, unusual weakness, or breathing that feels deeper or faster than usual. People with diabetes should not ignore a sudden change in how they feel, especially if they are also eating less, vomiting, or dealing with an infection.
Causes & Risk Factors
Synjardy is prescribed because type 2 diabetes is a long-term condition in which the body does not use insulin as effectively as it should. Over time, the liver may release too much glucose, the muscles and tissues may respond less efficiently to insulin, and blood sugar may remain above target even with healthy habits. A combination medicine can help address several of these pathways at once.
Certain factors often influence whether Synjardy is a good option. These include how high the blood sugar levels are, whether a person is already taking metformin or another diabetes medicine, and whether kidney function is strong enough for safe use. Age, hydration status, and a history of urinary or genital infections may also matter.
Other medicines can interact with diabetes treatment planning as well. People taking diuretics, insulin, or medicines that affect the kidneys may need closer monitoring. A careful medication review is especially important for patients traveling for care, because prescriptions, lab testing, and follow-up plans may need to be aligned before and after the trip.
Diagnosis
Before Synjardy is prescribed, a clinician usually confirms the diabetes diagnosis and reviews how well blood sugar is currently controlled. This may involve tests such as fasting glucose, HbA1c, and sometimes home glucose logs. These results help show whether a change in treatment is needed and how urgent that change may be.
Kidney function testing is an important part of the decision-making process. Because metformin and empagliflozin both require appropriate kidney assessment, the care team may order blood tests and review medical history before starting treatment. They may also check blood pressure, weight changes, and any history of dehydration or recurrent infections.
For some patients, especially those coming from abroad, diagnosis and prescribing happen as part of a structured diabetes consultation. That visit may also include nutrition guidance, medication reconciliation, and a plan for remote follow-up after returning home. The goal is not just to start a tablet, but to make sure the treatment fits the person’s overall medical picture.
Treatment Options
Synjardy is one treatment option within the wider approach to type 2 diabetes care. It may be used when metformin alone is not enough, or when a clinician wants to combine metformin with an SGLT2 inhibitor in a single tablet. The exact choice depends on the person’s glucose targets, kidney function, and the presence of other health conditions.
Because it contains metformin, some people notice stomach-related side effects when they first start therapy or when the dose is adjusted. Taking the medicine as directed and following the prescribing clinician’s instructions can help reduce problems. It is also important not to stop or restart the medicine on one’s own without advice, because diabetes treatment often needs careful adjustment.
In some cases, Synjardy may be part of a broader plan that also includes other medicines. A clinician might add insulin or another diabetes drug if blood sugar remains above goal. The broader plan often includes attention to blood pressure, cholesterol, foot care, eye screening, and weight management, since diabetes affects more than one system in the body.
- Medication review: checking all prescriptions and supplements before starting.
- Kidney monitoring: confirming the medicine remains appropriate over time.
- Blood sugar tracking: using home readings and HbA1c to guide care.
- Lifestyle support: pairing medicine with nutrition and activity changes.
Prevention & Self-care
Synjardy works best when it is part of a stable diabetes routine. Taking the medicine exactly as prescribed, maintaining regular meals when advised, and staying hydrated can all support better tolerance. People who are unwell with vomiting, diarrhea, fever, or poor fluid intake should speak with a clinician promptly, because temporary changes in treatment may be needed.
Self-care also includes paying attention to symptoms that may point to side effects or poor blood sugar control. Urinary or genital discomfort, marked thirst, lightheadedness, or an unusual sense of fatigue should not be brushed aside. Good daily care makes it easier to spot these changes early and discuss them with the diabetes team.
For patients managing diabetes from another country, self-care should include a clear written plan. That plan may list when to check glucose, what to do if a dose is missed, and how to reach a clinician for follow-up questions once home. Keeping medicine names, test results, and discharge instructions together in one place can make cross-border care much smoother.
When to See a Doctor
A doctor should be contacted before starting Synjardy if there is any history of kidney disease, recurrent urinary infections, severe dehydration, or previous problems with metformin. The same applies if another clinician has already raised concerns about kidney function, liver disease, or the safety of current medicines. A brief review can prevent avoidable complications.
Medical advice is also important if new symptoms appear after starting treatment, especially persistent nausea, vomiting, abdominal discomfort, dizziness, or signs of infection. People should seek urgent care for severe weakness, trouble breathing, confusion, or symptoms that feel out of proportion to routine side effects. These signs need prompt assessment, even if blood sugar readings are not extremely high.
International patients benefit from arranging follow-up before they travel back home, particularly if lab monitoring or dose review is expected soon after discharge. Acibadem Health Point’s multidisciplinary specialists and JCI-accredited hospitals diagnose and treat diabetes for international patients with coordinated follow-up planning. That kind of structure can help the medicine remain safe and effective after care continues elsewhere.
Frequently asked questions
What is Synjardy used for?
Synjardy is used to help adults with type 2 diabetes lower and manage blood sugar levels. It combines empagliflozin and metformin, which work in different ways to support glucose control. It is usually prescribed along with diet, exercise, and regular monitoring.
Can Synjardy be used for type 1 diabetes?
No, Synjardy is not used to treat type 1 diabetes. It is also not a treatment for diabetic ketoacidosis, which is a medical emergency. A clinician will confirm the right medicine based on the type of diabetes and overall health.
What side effects are most common with Synjardy?
Common side effects may include stomach upset, nausea, diarrhea, increased urination, dizziness, or dehydration-related symptoms. Some people may also develop urinary or genital irritation. Not everyone has side effects, but new or persistent symptoms should be discussed with a doctor.
Does Synjardy affect the kidneys?
Kidney function is important when a clinician considers Synjardy, because both ingredients require appropriate kidney assessment. The medicine may not be suitable for everyone with reduced kidney function. Ongoing monitoring helps keep treatment safer over time.
Should Synjardy be taken with food?
Many people are advised to take metformin-containing medicines with meals to help reduce stomach upset, but the exact instructions depend on the formulation and the prescribing clinician’s advice. The medicine should always be taken exactly as directed. If the routine is difficult to follow, the care team can suggest practical adjustments.
What should someone do if they miss a dose?
If a dose is missed, the safest next step is to follow the instructions given by the prescribing clinician or pharmacist. In general, people should not double up doses unless they have been told to do so. If missed doses happen often, the treatment plan may need review.
References
- American Diabetes Association
- National Institute of Diabetes and Digestive and Kidney Diseases
- U.S. Food and Drug Administration
- World Health Organization
- NHS
This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.
